These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9222048)

  • 1. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
    Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
    J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinupristin/dalfopristin attenuates the inflammatory response and reduces the concentration of neuron-specific enolase in the cerebrospinal fluid of rabbits with experimental Streptococcus pneumoniae meningitis.
    Trostdorf F; Reinert RR; Schmidt H; Nichterlein T; Stuertz K; Schmitz-Salue M; Sadowski I; Brück W; Nau R
    J Antimicrob Chemother; 1999 Jan; 43(1):87-94. PubMed ID: 10381105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous granulocyte colony-stimulating factor increases the release of tumour necrosis factor and interleukin-1beta into the cerebrospinal fluid, but does not inhibit the growth of Streptococcus pneumoniae in experimental meningitis.
    Schmidt H; Stuertz K; Brück W; Chen V; Stringaris AK; Fischer FR; Nau R
    Scand J Immunol; 1999 May; 49(5):481-6. PubMed ID: 10320640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of teichoic and lipoteichoic acids from 30 different strains of Streptococcus pneumoniae during exposure to ceftriaxone, meropenem, quinupristin/dalfopristin, rifampicin and trovafloxacin.
    Heer C; Stuertz K; Reinert RR; Mäder M; Nau R
    Infection; 2000; 28(1):13-20. PubMed ID: 10697785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental study of cerebrospinal fluid tumor necrosis factor-alpha release in penicillin- and cephalosporin-resistant pneumococcal meningitis treated with different antibiotic schedules.
    Vivas M; Force E; El Haj C; Tubau F; Ariza J; Cabellos C
    J Microbiol Immunol Infect; 2017 Aug; 50(4):435-439. PubMed ID: 26452467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
    Destache CJ; Pakiz CB; Dash AK; Larsen C
    Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit.
    Granert C; Raud J; Waage A; Lindquist L
    Infect Immun; 1999 May; 67(5):2071-4. PubMed ID: 10225856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis.
    McCoig CC; Wubbel L; Jafri HS; Lutsar I; Bastero R; Olsen K; Shelton S; Friedland IR; McCracken GH
    J Antimicrob Chemother; 1999 May; 43(5):683-8. PubMed ID: 10382890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin.
    Purswani M; Eckert S; Arora H; Johann-Liang R; Noel GJ
    J Antimicrob Chemother; 2000 Dec; 46(6):921-9. PubMed ID: 11102411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities.
    Nicolau DP; Tessier PR; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1998 Apr; 42(4):991-2. PubMed ID: 9559832
    [No Abstract]   [Full Text] [Related]  

  • 12. In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.
    Klugman KP; Gootz TD
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():51-5. PubMed ID: 9222070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
    Kim YS; Liu Q; Chow LL; Täuber MG
    Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.
    Stuertz K; Schmidt H; Trostdorf F; Eiffert H; Mäder M; Nau R
    Scand J Infect Dis; 1999; 31(4):367-70. PubMed ID: 10528875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to beta-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin.
    Stuertz K; Schmidt H; Eiffert H; Schwartz P; Mäder M; Nau R
    Antimicrob Agents Chemother; 1998 Feb; 42(2):277-81. PubMed ID: 9527772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of trovafloxacin in a mouse model of cephalosporin-resistant Streptococcus pneumoniae pneumonia.
    Ng W; Lutsar I; Wubbel L; Ghaffar F; Jafri H; McCracken GH; Friedland IR
    J Antimicrob Chemother; 1999 Jun; 43(6):811-6. PubMed ID: 10404320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin.
    Sáez-Llorens X; McCoig C; Feris JM; Vargas SL; Klugman KP; Hussey GD; Frenck RW; Falleiros-Carvalho LH; Arguedas AG; Bradley J; Arrieta AC; Wald ER; Pancorbo S; McCracken GH; Marques SR;
    Pediatr Infect Dis J; 2002 Jan; 21(1):14-22. PubMed ID: 11791092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
    López Fornas F; Martínez García F; Pérez Salmeron J; Roldán Conesa D; Cortés Sanchez R; García Alberola A; Ruíz Gómez J; Gómez Gómez J; Valdés Chávarri M
    J Antimicrob Chemother; 2001 May; 47(5):623-9. PubMed ID: 11328774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
    McCracken GH
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S45-50. PubMed ID: 10984328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin in the therapy of experimental pneumococcal meningitis.
    Schmidt H; Dalhoff A; Stuertz K; Trostdorf F; Chen V; Schneider O; Kohlsdorfer C; Brück W; Nau R
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1397-407. PubMed ID: 9624483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.